Member Info for CHELSEA7

Discounted cash flow (DCF) is a valuation method used to estimate the attractiveness of an investment opportunity. ... If the value arrived at through DCF analysis is higher than the current cost of the investment, the opportunity may be a good one.

28/11/2018 13:09 25,000 7.82
28/11/2018 10:37 50,000 8.2

How can posting research be ""counter productive"??? Staggering comment, or is it there is not much peer reviewed to post.

A good science, well one that doesn"t attract collaborators or investors, nor meet endpoints. We hhave the same information, two very different opinions, one is financially involved, the other isn"t. You might find there are even less investors by not posting or sharing research!!!

Ray,
Would appreciate that.

Couldn"t agree more Deadly, if anything too Genentech/BioNTech and Scancell can only really discuss figures after the GC Results are known.

Not taking funding for granted, far from it, but the MMs treatment of the M/Cap reflects it is no foregone conclusion.

Didn"t realise that Ray, mind you it makes sense for CRUK too, under the terms of the agreement.

Interesting what you say about the opposition, i find it difficult to determine their credentials.

Keeps coming back to me whether we think we have a reasonable chance of securing the funding we need, even another dilution in the 20s, with the strategy we have in place. I think we do, and lets face it with the SPs performance the rewards in doing so are only higher.

Roses, have we opted to be covered by Trinity instead of Hardman Research?

Yep I would go along with that. A nice deal with BioNTech would go down rather well?

Never heard the name Tommy, but that doesn"t mean a definate no.

Val Ju, Ray is correct, it is impossible to put a value on VAL without researching the market and seeing whaqt the market has lined up, are VAL ahead of competition, even what is the competition. I tend to do that and it is far more productive than saying next month we will conclude the deal for £2b.month after month, based on nothing.

Then of course as somebody just said many of us are just down, not wanting to take the loss, and waiting for a miracle. On that basis being called all the names under the sun is just a little bit childish?

Bwgs, morning. But you do spend time posting positively about VAL most days. Whats the difference, every buy has a sell, its called a market,

https://www.investegate.co.uk/oncimmune-hldngs-plc--onc-/rns/distribution-agreements---registration-outside-eu/201811280710457321I/

Oncimmune early CDT Lung Distribution Agreements RNS...........................

https://www.investegate.co.uk/oncimmune-hldngs-plc--onc-/rns/distribution-agreements---registration-outside-eu/201811280710457321I/

No problem researcher. Well done, slightly more important things on my mind. ATB

Well 7.50/8. GL, we need it.

Night guys

Well fourteen and scooby doo will be there!!

Absolutely

Thank you Obelix.ATB

27/11/2018 10:26 41,500 8.32
27/11/2018 09:14 744 8.32

Both buys

And even winning prize money, we will still need further funding to cover all platforms development.

Lets face it the only real news we want to hear is how much and when to buy. At least we know we have foundations to build on, in place, SCIB1 funded, and CRUK funding SCIB2. There might well be no sentiment with us, but we are moving forward. IMHO